YBX3 and nonpapillary renal cell carcinoma: Secondly, the expression of YBX3 was found to be markedly higher in ccRCC specimens (n = 541, P = 4.27e-33, 95% CI: 1.4476–1.777) compared with the paracancerous samples (n = 72) in TCGA KIRC dataset (Fig. 1B).